Related Experiment Video
Updated: Nov 20, 2025

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
The Desmin (DES) Mutation p.A337P Is Associated with Left-Ventricular Non-Compaction Cardiomyopathy
Olga Kulikova1, Andreas Brodehl2, Anna Kiseleva1
1National Medical Research Center for Therapy and Preventive Medicine, Petroverigsky per., 10, bld. 3, 101000 Moscow, Russia.
Insights
A Russian family with left-ventricular non-compaction cardiomyopathy (LVNC) and skeletal myopathy was studied. Genetic analysis revealed a pathogenic DES mutation, suggesting its inclusion in LVNC genetic testing, especially with muscle involvement.
Area of Science:
- Cardiology
- Genetics
- Cell Biology
Background:
- Left-ventricular non-compaction cardiomyopathy (LVNC) is a rare congenital heart defect.
- Skeletal myopathy can co-occur with cardiac conditions, suggesting shared genetic or molecular pathways.
Observation:
- A Russian family presented with LVNC and skeletal myopathy.
- Next-generation sequencing identified a shared mutation in the DES gene (p.A337P) in affected individuals.
- The index patient also carried a DSP mutation (p.L1348X).
Findings:
- The DES-p.A337P mutation was investigated in vitro.
- Desmin-p.A337P formed cytoplasmic aggregates in transfected cells and cardiomyocytes, confirming pathogenicity.
- The DES gene encodes desmin, a crucial protein in muscle intermediate filaments.
Implications:
- The DES gene should be considered in the genetic analysis of LVNC patients.
- This finding is particularly relevant for LVNC cases with co-existing skeletal muscle involvement.
- Understanding desmin's role in LVNC may lead to new diagnostic and therapeutic strategies.
Abstract:
Here, we present a small Russian family, where the index patient received a diagnosis of left-ventricular non-compaction cardiomyopathy (LVNC) in combination with a skeletal myopathy. Clinical follow-up analysis revealed a LVNC phenotype also in her son. Therefore, we applied a broad next-generation sequencing gene panel approach for the identification of the underlying mutation. Interestingly, DES-p.A337P was identified in the genomes of both patients, whereas only the index patient carried DSP-p.L1348X. DES encodes the muscle-specific intermediate filament protein desmin and DSP encodes desmoplakin, which is a cytolinker protein connecting desmosomes with the intermediate filaments. Because the majority of DES mutations cause severe filament assembly defects and because this mutation was found in both affected patients, we analyzed this DES mutation in vitro by cell transfection experiments in combination with confocal microscopy. Of note, desmin-p.A337P forms cytoplasmic aggregates in transfected SW-13 cells and in cardiomyocytes derived from induced pluripotent stem cells underlining its pathogenicity. In conclusion, we suggest including the DES gene in the genetic analysis for LVNC patients in the future, especially if clinical involvement of the skeletal muscle is present.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
Mitral Stenosis I: Introduction

